Modulation of multidrug resistance by verapamil ormdr1 anti-sense oligodeoxynucleotide does not change the high susceptibility to lymphokine-activated killers inmdr-resistant human carcinoma (LoVo) line-Reference-Cited by-同舟云学术

Modulation of multidrug resistance by verapamil ormdr1 anti-sense oligodeoxynucleotide does not change the high susceptibility to lymphokine-activated killers inmdr-resistant human carcinoma (LoVo) line

Published:1990-10-15 Issue:4 Volume:46 Page:727-732
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Rivoltini Licia,Colombo Mario P.,Supino Rosanna,Ballinari Dario,Tsuruo Takashi,Parmiani Giorgio

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference29 articles.

1. Human tumor cell lines with pleiotropic drug resistance are efficiently killed by interleukin-2 activated killer cells and by activated monocytes

2. Functions and mechanisms of lysis induced by cytotoxic T lymphocytes and natural killer cells. In: (ed.), Fundamental Immunology, 2nd ed., pp. 735–764, Raven Press, New York (1989).

3. Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein.

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies to enhance the response of liver cancer to pharmacological treatments;American Journal of Physiology-Cell Physiology;2024-07-01

2. Liver and gastrointestinal cancers;Drug Efflux Pumps in Cancer Resistance Pathways: From Molecular Recognition and Characterization to Possible Inhibition Strategies in Chemotherapy;2020

3. Oxidative stress-based cytotoxicity of delphinidin and cyanidin in colon cancer cells;Archives of Biochemistry and Biophysics;2010-09

4. Cytotoxic T-lymphocytes recognizing P-glycoprotein in murine multidrug-resistant leukemias;European Journal of Haematology;2009-04-24

5. DNA Binding Ellipticine Analogues: Synthesis, Biological Evaluation, and Structure-Activity Relationships;ChemMedChem;2009-03-16